Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
500.49
+4.66 (0.94%)
At close: Apr 15, 2025, 4:00 PM
493.46
-7.03 (-1.40%)
After-hours: Apr 15, 2025, 7:26 PM EDT

Vertex Pharmaceuticals Market Cap

Vertex Pharmaceuticals has a market cap or net worth of $128.52 billion as of April 15, 2025. Its market cap has increased by 19.03% in one year.

Market Cap
128.52B
Enterprise Value
119.05B
1-Year Change
19.03%
Ranking
Category
Stock Price
$500.49

Market Cap Chart

Since December 1, 1998, Vertex Pharmaceuticals's market cap has increased from $611.50M to $128.52B, an increase of 20,917.30%. That is a compound annual growth rate of 22.47%.

History

DateMarket Cap% Change
Apr 14, 2025127.32B22.77%
Dec 31, 2024103.71B-1.09%
Dec 29, 2023104.85B41.44%
Dec 30, 202274.13B32.76%
Dec 31, 202155.83B-9.15%
Dec 31, 202061.46B9.15%
Dec 31, 201956.30B32.95%
Dec 31, 201842.35B11.74%
Dec 29, 201737.90B107.41%
Dec 30, 201618.27B-40.90%
Dec 31, 201530.92B8.21%
Dec 31, 201428.57B64.52%
Dec 31, 201317.37B91.17%
Dec 31, 20129.09B31.16%
Dec 30, 20116.93B-2.69%
Dec 31, 20107.12B-8.32%
Dec 31, 20097.76B69.85%
Dec 31, 20084.57B48.74%
Dec 31, 20073.07B-34.61%
Dec 29, 20064.70B71.34%
Dec 30, 20052.74B223.10%
Dec 31, 2004848.90M5.56%
Dec 31, 2003804.20M-33.56%
Dec 31, 20021.21B-34.33%
Dec 31, 20011.84B-56.32%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 202.51B
Novartis AG 200.23B
Thermo Fisher Scientific 165.40B
Danaher 135.03B
Stryker 133.70B
Sanofi 124.23B
Medtronic 106.32B
McKesson 86.39B
Market Cap Rankings